Faculty of physical therapy
Cairo, Giza, Dokki, 11432, Egypt
Location contact
Nesreen G Alnahas, Professor
CONTACT
1002227242 ext. +20
Rana H Elbanna, Assist.Prof
CONTACT
1062070686 ext. +20
NCT Number: NCT07566702
The goal of this clinical trial study: is to determine the effectiveness of neuromuscular electrical stimulation in critically ill patients undergoing extracorporeal membrane oxygenation.
The main questions it aims to answer are:
* Does NMES has an effect when added to conventional protocol for ECMO patients? * Does NMES will help in preserve muscle mass? * Patients will recieve the treatment untill discharge. * Assesment will be done before and after treatement
Trial opening soon.
Get Notified20 year–50 year
All sexes
Interventional
Not applicable
Cairo, Giza, Dokki, 11432, Egypt
Nesreen G Alnahas, Professor
CONTACT
1002227242 ext. +20
Rana H Elbanna, Assist.Prof
CONTACT
1062070686 ext. +20
Fifty Patients from both genders with pulmonary or cardiac disease receiving extracorporeal membrane oxygenation will participate in this study. They will randomly have divided into two groups equal in numb.Their ages will be ranged from 20 to 50 years.
In this study the patients will be randomly assigned into two equal groups (25 patients for each group):
This group includes 25 patients who will receive VMS current of NMES on quadriceps muscle bilateral for 30 min daily for one week in addition to conventional physiotherapy program (Range of motion exercises, Positioning,Strengthening exercises and Stretching exercises).
This group will include 25 patients. The participants will receive conventional physiotherapy program (Range of motion exercises, Positioning,Strengthening exercises and Stretching exercises) two times per day for one week.
Measurement equipments:
A-Evaluating muscle strength The Medical Research Council (MRC) Scale for Muscle Strength B-Evaluating muscle mass Ultrasonography for assessing quadriceps muscle mass applied by ACUSON P500 manufactured by SEIMENS made in USA C-Evaluating level of activity ICU Mobility scale (IMS): IMS provides a sensitive 11-point ordinal scale, ranging from nothing (lying/passive exercises in bed, score of 0) to independent ambulation (score of 10).
D- Hospital length of stay (LOS) days E-Discharge destination Discharge destination was ranked on an ordinal scale: 0 = mortality; 1 = discharge to inpatient hospice; 2 = discharge to long-term acute care facility equivalent to ventilator weaning and skilled nursing facilities; 3 = discharge to acute and subacute care rehabilitation facilities; 4 = discharge to home with home health rehabilitation services; and 5 = discharge to home with no services.
F- Incidence and type of ECMO complication
The conventional program for both groups:
(Early mobilization started passively and progressed to be active, and progressed from in bed mobility to out of bed mobility, Mobilization activities, Passive- and active-assisted movements of extremities, Sitting on a chair, Bedside standing, Walking with support).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NMES will be applied bilaterally to the quadriceps femoris muscles (rectus femoris and vastus intermedius) for 30 minutes daily for one week. Stimulation parameters will include a frequency of 50 pulses per second, pulse duration of 1000 microseconds, ramp time of 5 seconds, and a duty cycle of 1:5. Two rectangular carbon electrodes (6 × 8 cm) will be placed over the motor points of the targeted muscles. Patients will be positioned in supine lying with approximately 40 degrees knee flexion.
In addition, participants will receive a conventional physiotherapy program twice daily, including passive and active-assisted range of motion exercises, early mobilization, bed mobility, sitting, standing, and ambulation.
Participants in this group will receive a conventional physiotherapy program only during extracorporeal membrane oxygenation (ECMO) support. The program will be administered twice daily for one week.
The intervention will include early mobilization strategies starting with passive range of motion exercises and progressing to active-assisted and active exercises as tolerated. Rehabilitation activities will include bed mobility, sitting at the edge of the bed, bedside standing, and assisted ambulation according to patient tolerance and clinical stability.
All interventions will be delivered according to standard ICU physiotherapy practices. Neuromuscular electrical stimulation (NMES) will not be applied in this group.
Other names: Conventional physiotherapy
Time frame: Baseline and after 7 days of intervention
Quadriceps muscle mass will be assessed using ultrasonography by measuring muscle thickness and/or cross-sectional area of the rectus femoris muscle. Measurements will be performed at baseline (before intervention) and after one week of intervention during ECMO support. The primary endpoint will be the change in muscle mass over time between groups.
Time frame: Baseline and after 7 days of intervention
Muscle strength will be assessed using the Medical Research Council (MRC) scale for major muscle groups. The total MRC score will be recorded to evaluate global muscle strength.
Time frame: Baseline and after 7 days of intervention
Functional mobility will be assessed using the ICU Mobility Scale (IMS), an 11-point ordinal scale ranging from 0 (lying in bed) to 10 (independent ambulation).
Time frame: From day 1 up to 90 days
Length of hospital stay will be measured as the total number of days from ICU admission to hospital discharge.
Time frame: From day 1 up to 90 days
Discharge destination will be assessed using an ordinal scale:
0 = mortality;
Contact information is provided by the study sponsor or research team.
Ehssan R Mahmoud, Master
CONTACT
1096403137 ext. +20
Rana H Elbanna, Assist.Prof
CONTACT
1062070686 ext. +20
Cairo University
Other
Effectiveness of Neuromuscular Electrical Stimulation in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation
Acronym: NMES-ECMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07466862
Anosmia, Atrophy
Petah Tikva, Israel
View Trial Details